1. Home
  2. FEAM vs HOWL Comparison

FEAM vs HOWL Comparison

Compare FEAM & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$2.30

Market Cap

56.9M

Sector

Industrials

ML Signal

HOLD

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

46.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
HOWL
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
46.7M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
FEAM
HOWL
Price
$2.30
$1.01
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $5.88
N/A
AVG Volume (30 Days)
★ 766.5K
455.5K
Earning Date
11-12-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 63.80
18.40
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$81.81
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.90
$0.27
52 Week High
$6.03
$1.83

Technical Indicators

Market Signals
Indicator
FEAM
HOWL
Relative Strength Index (RSI) 41.42 57.50
Support Level $1.38 $0.86
Resistance Level $2.49 $1.14
Average True Range (ATR) 0.45 0.05
MACD -0.18 -0.00
Stochastic Oscillator 3.15 50.82

Price Performance

Historical Comparison
FEAM
HOWL

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

Share on Social Networks: